Table 2 Comparison of PFT parameters between event and event-free patients with IPAH
All patients | Male patients | Female patients | ||||
---|---|---|---|---|---|---|
Event (n=24) | Event-free (n=33) | Event (n=9) | Event-free (n=12) | Event (n=15) | Event-free (n=21) | |
FVC, l | 3.0±0.7 | 3.0±0.7 | 3.8±0.4 | 3.7±0.7 | 2.5±0.4a | 2.6±0.4b |
FVC %Pred | 83.4±13.6 | 85.2±12.8 | 92.1±13.9 | 93.1±14.2 | 78.8±11.4a | 80.5±9.4b |
FEV1, l | 2.4±0.6 | 2.4±0.6 | 3.0±0.5 | 2.9±0.6 | 2.1±0.5a | 2.1±0.3b |
FEV1 %Pred | 80.0±16.3 | 81.4±11.2 | 88.8±18.7 | 86.4±14.1 | 75.0±13.2 | 78.4±7.9 |
FEV1/FVC, % | 78.0±17.8 | 78.4±15.6 | 69.9±26.5 | 78.7±8.7 | 82.3±9.6 | 78.3±18.8 |
MVV, l min−1 | 72.9±33.0 | 74.4±22.3 | 96.5±35.6 | 89.5±26.3 | 60.1±24.1a | 65.4±13.5b |
MVV %Pred | 78.5±31.5 | 80.4±18.8 | 92.4±35.9 | 87.0±20.2 | 71.1±27.3 | 76.5±17.1 |
DLCO, ml mm Hg−1 min−1 | 17.1±5.3 | 17.5±4.4 | 18.4±8.2 | 19.7±5.3 | 16.5±3.2 | 16.2±3.2 |
DLCO %Pred | 80.0±17.5 | 83.6±13.1 | 72.8±21.3 | 82.5±15.3 | 83.6±14.6 | 84.3±11.9 |
TLC, l | 5.0±1.0 | 4.9±1.0 | 6.1±0.3 | 5.9±0.7 | 4.5±0.7a | 4.3±0.5b |
TLC %Pred | 97.8±15.2 | 95.8±12.6 | 100.9±11.2 | 101.4±15.5 | 96.2±17.0 | 92.4±9.4 |